Covid-19, Hospitalized, PatIents, Nasafytol

Clinical trial NCT04844658 · COMPLETED

Trial details

NCT number: NCT04844658
Sponsor: Tilman S.A.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronavirus Infection

Start date: 2021-02-17
Primary completion: 2021-10-29
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.